Osenvelt 120 mg/1.7 mL (70 mg/mL) single-dose vial Images
Generic Name: denosumab
This medication has been identified as Osenvelt 120 mg/1.7 mL (70 mg/mL) single-dose vial. It is supplied by Celltrion USA.
Osenvelt is used in the treatment of Osteolytic Bone Metastases of Solid Tumors; Osteolytic Bone Lesions of Multiple Myeloma; Giant Cell Tumor of Bone; Hypercalcemia of Malignancy and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Osenvelt 120 mg/1.7 mL (70 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Osenvelt
- Generic Name
- denosumab
- Strength
- 120 mg/1.7 mL (70 mg/mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celltrion USA
- National Drug Code (NDC)
- 72606-0038
See also:
More about Osenvelt (denosumab)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
Patient resources
Other brands
Prolia, Xgeva, Jubbonti, Wyost
Professional resources
Other brands
Prolia, Xgeva, Jubbonti, Wyost, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.